683 Capital Management, LLC - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
683 Capital Management, LLC ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4,360,000
-42.1%
500,000
-58.3%
0.32%
-49.0%
Q4 2022$7,524,000
+46.2%
1,200,000
-18.4%
0.64%
+60.1%
Q3 2022$5,145,000
+18.6%
1,470,0000.0%0.40%
+30.1%
Q2 2022$4,338,000
+26.8%
1,470,000
+33.6%
0.31%
+67.2%
Q1 2022$3,422,000
-8.0%
1,100,0000.0%0.18%
+33.6%
Q4 2021$3,718,0001,100,0000.14%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders